McKesson stock soars to all-time high of $728.49 amid robust growth

McKesson Corporation (NYSE:MCK)’s stock has reached an unprecedented peak, touching an all-time high of $728.49. With a market capitalization of $90.89 billion and an impressive YTD return of 27.6%, InvestingPro analysis indicates the stock is trading near its Fair Value. This milestone underscores a period of significant growth for the healthcare services and information technology company, reflecting investor confidence and a robust performance in the healthcare sector. Over the past year, McKesson’s stock has witnessed a remarkable ascent, with a 1-year return of 29.39%. This surge in stock value is supported by the company’s GREAT financial health score of 3.21 on InvestingPro, which offers 16 additional valuable insights about MCK’s performance and outlook in their comprehensive Pro Research Report.

In other recent news, McKesson Corporation reported robust financial results for the fourth quarter, exceeding Wall Street’s expectations with earnings per share (EPS) outperforming consensus estimates by 3%. The company announced a fiscal year 2026 EPS guidance that surpasses current market expectations, maintaining a long-term EPS growth outlook of 12%-14%. Despite the EPS beat, McKesson’s Q3 2025 revenue fell short of forecasts, coming in at $90.82 billion against a projected $93.48 billion, which raised concerns among investors. Jefferies analyst Rob Dickerson responded to these developments by raising McKesson’s stock price target to $800 and maintaining a Buy rating, citing confidence in the company’s growth trajectory.

Additionally, McKesson’s strategic acquisitions, including controlling interests in Prism Vision and pending acquisitions in CORE Ventures, continue to bolster its position in the healthcare services sector. The company has projected a revenue growth guidance of 11% to 15% for fiscal 2026. McKesson’s management also announced plans to separate its Medical (TASE:BLWV) Surgical segment into an independent entity, aiming to enhance focus and operational efficiency. This move is expected to unlock significant value for both McKesson and the new company. Furthermore, McKesson’s cost optimization efforts have resulted in $100 million in savings, contributing to its strong financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.